DeepMed Research

Maria Sklodowska-Curie National Research Institute of Oncology

🇵🇱Poland

Country: 🇵🇱Poland

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: https://www.pib-nio.pl/

Clinical Trials

Effect of an Advanced Notification Letter on Screening Colonoscopy Participation

Not Applicable

Conditions: Colorectal Cancer
Rectal Cancer
Adenoma

Interventions: Behavioral: No included ANL
Other: Implementation of ANL

First Posted Date: 2014-07-14

Last Posted Date: 2014-07-14

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 6800

Registration Number: NCT02188927

Locations: 🇵🇱
The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland, Warsaw, Mazovian, Poland

Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease

Conditions: Ulcerative Colitis
Inflammatory Bowel Disease
Crohn's Disease
Indeterminate Colitis

First Posted Date: 2014-02-19

Last Posted Date: 2015-04-07

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 400

Registration Number: NCT02066272

Locations: 🇵🇱
Department of Gastroenterology and Hepatology, Medical Center for Postgraduate Education and The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Mazowieckie, Poland
🇵🇱
Department of Gastroenterology, Hepatology and Feeding Disorders, The Children's Memorial Health Institute, Warsaw, Mazowieckie, Poland

The Effect of Routine Video-recording on Colonoscopy Quality Indicators.

Not Applicable

Completed

Conditions: Colorectal Cancer

Interventions: Procedure: Implementation of routine videorecording
Behavioral: No routine videorecording

First Posted Date: 2014-02-04

Last Posted Date: 2015-08-05

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 5200

Registration Number: NCT02054923

Locations: 🇵🇱
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland

Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.

Phase 3

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Cytosine arabinoside + G-CSF (filgrastim)
Drug: G-CSF (filgrastim)

First Posted Date: 2013-07-25

Last Posted Date: 2018-08-28

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 90

Registration Number: NCT01908621

Locations: 🇵🇱
Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Gliwice, Poland

Organ Preservation in Elderly Patients With Rectal Cancer

Not Applicable

Conditions: Rectal Cancer

Interventions: Radiation: Radiochemotherapy or radiotherapy

First Posted Date: 2013-05-29

Last Posted Date: 2019-03-29

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 90

Registration Number: NCT01863862

Locations: 🇵🇱
M. Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland

Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer

Phase 3

Conditions: Prostate Cancer

Interventions: Radiation: CF-CRT combined with BT or SBRT boost.
Radiation: CF-CRT alone
Drug: Hormonal treatment (neoadjuvant androgen deprivation)

First Posted Date: 2013-04-25

Last Posted Date: 2013-04-25

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 350

Registration Number: NCT01839994

Locations: 🇵🇱
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Silesia, Poland

Preoperative Hyperfractionated Radiotherapy or Radiochemotherapy in Locally Advanced Rectal Cancer.

Phase 3

Conditions: Rectal Cancer

Interventions: Radiation: Hyperfractionated Radiotherapy
Radiation: Hyperfractionated Radiochemotherapy

First Posted Date: 2013-03-20

Last Posted Date: 2015-05-05

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 260

Registration Number: NCT01814969

Locations: 🇵🇱
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Wybrzeze AK 15, Poland

Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies.

Phase 1

Conditions: Leukemia
Lymphoma

Interventions: Procedure: Intrabone transplantation

First Posted Date: 2012-11-19

Last Posted Date: 2013-07-24

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 10

Registration Number: NCT01728389

Locations: 🇵🇱
MSC Memorial CAncer Center and Institute of Oncology, Gliwice, Poland

The Magnitude of Effect of PCP Counseling on Participation Rate and Sedation Rate in Colonoscopy-based Screening Program

Not Applicable

Completed

Conditions: Colorectal Neoplasms

Interventions: Other: Physician's counseling
Other: Information leaflet

First Posted Date: 2012-09-20

Last Posted Date: 2012-09-26

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 600

Registration Number: NCT01688817

Randomized Study of Train the Colonoscopy Leaders Course Versus Audit and Feedback on Colonoscopy Quality Indicators

Not Applicable

Completed

Conditions: Colorectal Cancer

Interventions: Procedure: Train the leaders course
Behavioral: Audit and feedback

First Posted Date: 2012-08-17

Last Posted Date: 2014-04-16

Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

Target Recruit Count: 40

Registration Number: NCT01667198

Locations: 🇵🇱
The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy